S&P 500   3,402.30 (+0.04%)
DOW   27,613.29 (-0.26%)
QQQ   282.25 (+0.63%)
AAPL   116.21 (+1.01%)
MSFT   212.11 (+0.97%)
FB   282.70 (+2.02%)
GOOGL   1,589.12 (+0.30%)
AMZN   3,255.00 (+1.50%)
TSLA   428.49 (+1.95%)
NVDA   533.33 (+1.46%)
BABA   314.52 (+2.49%)
CGC   18.89 (+1.94%)
GE   7.18 (-2.71%)
MU   51.92 (-0.42%)
AMD   79.14 (-3.76%)
T   27.05 (-1.21%)
F   8.02 (-0.12%)
ACB   4.23 (-3.86%)
GILD   59.95 (-0.02%)
NFLX   486.37 (-0.38%)
NIO   27.59 (+6.07%)
BA   158.01 (-1.75%)
DIS   123.94 (-0.10%)
S&P 500   3,402.30 (+0.04%)
DOW   27,613.29 (-0.26%)
QQQ   282.25 (+0.63%)
AAPL   116.21 (+1.01%)
MSFT   212.11 (+0.97%)
FB   282.70 (+2.02%)
GOOGL   1,589.12 (+0.30%)
AMZN   3,255.00 (+1.50%)
TSLA   428.49 (+1.95%)
NVDA   533.33 (+1.46%)
BABA   314.52 (+2.49%)
CGC   18.89 (+1.94%)
GE   7.18 (-2.71%)
MU   51.92 (-0.42%)
AMD   79.14 (-3.76%)
T   27.05 (-1.21%)
F   8.02 (-0.12%)
ACB   4.23 (-3.86%)
GILD   59.95 (-0.02%)
NFLX   486.37 (-0.38%)
NIO   27.59 (+6.07%)
BA   158.01 (-1.75%)
DIS   123.94 (-0.10%)
S&P 500   3,402.30 (+0.04%)
DOW   27,613.29 (-0.26%)
QQQ   282.25 (+0.63%)
AAPL   116.21 (+1.01%)
MSFT   212.11 (+0.97%)
FB   282.70 (+2.02%)
GOOGL   1,589.12 (+0.30%)
AMZN   3,255.00 (+1.50%)
TSLA   428.49 (+1.95%)
NVDA   533.33 (+1.46%)
BABA   314.52 (+2.49%)
CGC   18.89 (+1.94%)
GE   7.18 (-2.71%)
MU   51.92 (-0.42%)
AMD   79.14 (-3.76%)
T   27.05 (-1.21%)
F   8.02 (-0.12%)
ACB   4.23 (-3.86%)
GILD   59.95 (-0.02%)
NFLX   486.37 (-0.38%)
NIO   27.59 (+6.07%)
BA   158.01 (-1.75%)
DIS   123.94 (-0.10%)
S&P 500   3,402.30 (+0.04%)
DOW   27,613.29 (-0.26%)
QQQ   282.25 (+0.63%)
AAPL   116.21 (+1.01%)
MSFT   212.11 (+0.97%)
FB   282.70 (+2.02%)
GOOGL   1,589.12 (+0.30%)
AMZN   3,255.00 (+1.50%)
TSLA   428.49 (+1.95%)
NVDA   533.33 (+1.46%)
BABA   314.52 (+2.49%)
CGC   18.89 (+1.94%)
GE   7.18 (-2.71%)
MU   51.92 (-0.42%)
AMD   79.14 (-3.76%)
T   27.05 (-1.21%)
F   8.02 (-0.12%)
ACB   4.23 (-3.86%)
GILD   59.95 (-0.02%)
NFLX   486.37 (-0.38%)
NIO   27.59 (+6.07%)
BA   158.01 (-1.75%)
DIS   123.94 (-0.10%)
Log in
NASDAQ:ANGO

AngioDynamics Stock Forecast, Price & News

$11.19
+0.19 (+1.73 %)
(As of 10/27/2020 10:50 AM ET)
Add
Compare
Today's Range
$11.07
Now: $11.19
$11.31
50-Day Range
$9.10
MA: $10.62
$12.74
52-Week Range
$7.48
Now: $11.19
$17.24
Volume759 shs
Average Volume408,404 shs
Market Capitalization$424.66 million
P/E RatioN/A
Dividend YieldN/A
Beta0.5
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides vascular interventions and therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
Read More
AngioDynamics logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.34 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:ANGO
CUSIP03475V10
Phone518-795-1400
Employees800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$264.16 million
Cash Flow$0.73 per share
Book Value$12.09 per share

Profitability

Net Income$-166,790,000.00

Miscellaneous

Market Cap$424.66 million
Next Earnings Date1/5/2021 (Estimated)
OptionableOptionable
$11.19
+0.19 (+1.73 %)
(As of 10/27/2020 10:50 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ANGO News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AngioDynamics (NASDAQ:ANGO) Frequently Asked Questions

How has AngioDynamics' stock been impacted by COVID-19?

AngioDynamics' stock was trading at $10.14 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ANGO stock has increased by 8.5% and is now trading at $11.00.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of AngioDynamics?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AngioDynamics in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for AngioDynamics
.

When is AngioDynamics' next earnings date?

AngioDynamics is scheduled to release its next quarterly earnings announcement on Tuesday, January 5th 2021.
View our earnings forecast for AngioDynamics
.

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) posted its earnings results on Sunday, October, 4th. The medical instruments supplier reported $0.02 earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.09. The medical instruments supplier earned $70.20 million during the quarter, compared to analysts' expectations of $65.10 million. AngioDynamics had a positive return on equity of 0.18% and a negative net margin of 62.90%. The firm's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.08 earnings per share.
View AngioDynamics' earnings history
.

What guidance has AngioDynamics issued on next quarter's earnings?

AngioDynamics issued an update on its FY21 earnings guidance on Tuesday, September, 29th. The company provided earnings per share guidance of $0.00-0.05 for the period, compared to the Thomson Reuters consensus EPS estimate of ($0.10). The company issued revenue guidance of $278-285 million, compared to the consensus revenue estimate of $274.48 million.

What price target have analysts set for ANGO?

1 analysts have issued 1-year target prices for AngioDynamics' shares. Their forecasts range from $14.00 to $14.00. On average, they expect AngioDynamics' stock price to reach $14.00 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price.
View analysts' price targets for AngioDynamics
.

Are investors shorting AngioDynamics?

AngioDynamics saw a decline in short interest in September. As of September 15th, there was short interest totaling 849,900 shares, a decline of 10.8% from the August 31st total of 952,500 shares. Based on an average trading volume of 266,100 shares, the days-to-cover ratio is currently 3.2 days. Currently, 2.3% of the shares of the stock are sold short.
View AngioDynamics' Short Interest
.

Who are some of AngioDynamics' key competitors?

What other stocks do shareholders of AngioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AngioDynamics investors own include General Electric (GE), Intel (INTC), Oasis Petroleum (OAS), Advanced Micro Devices (AMD), Freeport-McMoRan (FCX), Amicus Therapeutics (FOLD), Rigel Pharmaceuticals (RIGL), Accuray (ARAY), Celldex Therapeutics (CLDX) and Chimerix (CMRX).

Who are AngioDynamics' key executives?

AngioDynamics' management team includes the following people:
  • Mr. James C. Clemmer, CEO, Pres & Director (Age 56, Pay $1.33M)
  • Mr. Stephen A. Trowbridge, Exec. VP & CFO (Age 46, Pay $629.55k)
  • Mr. David D. Helsel, Sr. VP of Global Operations and R&D (Age 56, Pay $522.12k)
  • Mr. Scott Centea, Sr. VP & GM of Vascular Interventions and Therapies & Peripheral Artery Disease (Age 42, Pay $558.54k)
  • Mr. Benjamin H. Davis, Sr. VP of Bus. Devel. (Age 56)

What is AngioDynamics' stock symbol?

AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO."

Who are AngioDynamics' major shareholders?

AngioDynamics' stock is owned by a number of retail and institutional investors. Top institutional investors include Assenagon Asset Management S.A. (1.76%), Paradigm Capital Management Inc. NY (0.35%), Envestnet Asset Management Inc. (0.11%), Louisiana State Employees Retirement System (0.05%), First Citizens Bank & Trust Co. (0.04%) and 6 Meridian (0.03%). Company insiders that own AngioDynamics stock include James C Clemmer, Kevin J Gould, Michael Greiner and Stephen A Trowbridge.
View institutional ownership trends for AngioDynamics
.

Which institutional investors are selling AngioDynamics stock?

ANGO stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Nisa Investment Advisors LLC, and First Citizens Bank & Trust Co..
View insider buying and selling activity for AngioDynamics
.

Which institutional investors are buying AngioDynamics stock?

ANGO stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Paradigm Capital Management Inc. NY, Louisiana State Employees Retirement System, and 6 Meridian. Company insiders that have bought AngioDynamics stock in the last two years include James C Clemmer, and Stephen A Trowbridge.
View insider buying and selling activity for AngioDynamics
.

How do I buy shares of AngioDynamics?

Shares of ANGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AngioDynamics' stock price today?

One share of ANGO stock can currently be purchased for approximately $11.00.

How big of a company is AngioDynamics?

AngioDynamics has a market capitalization of $417.45 million and generates $264.16 million in revenue each year. The medical instruments supplier earns $-166,790,000.00 in net income (profit) each year or $0.09 on an earnings per share basis. AngioDynamics employs 800 workers across the globe.

What is AngioDynamics' official website?

The official website for AngioDynamics is www.angiodynamics.com.

How can I contact AngioDynamics?

AngioDynamics' mailing address is 14 PLAZA DRIVE, LATHAM NY, 12110. The medical instruments supplier can be reached via phone at 518-795-1400 or via email at [email protected]roup.com.

This page was last updated on 10/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.